As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints The ...

Charting, Price Performance, News & Related Contracts.

Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with ...

CHICAGO, Jan. 15, 2026 /PRNewswire/ -- The Alzheimer's Association Dementia Care Navigation Roundtable (DCNR) today released a new white paper offering guidance to help health care organizations build ...

The Alzheimer’s Association will host Picklers Go Purple, a pickleball fundraiser from noon to 4 p.m. Jan. 24 at Picklers ...

In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, the ...

Transverse colon samples from confirmed Alzheimer’s disease cases showed distinct gut microbiome and proteomic shifts, ...

Armed with preliminary clinical data, US start-up Alzheon has raised $10 million to help take its oral Alzheimer's therapy ALZ-801 into a phase II/III trial. The financing means that Alzheon can now ...

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug, which ...

Coming off wins over Georgia and Tennessee, the Florida Gators are looking to carry over momentum into Tuesday's matchup at ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...